PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In Vivo
Proprotein convertase subtilin/kexin type 9 (PCSK9) is a protease secreted mainly by hepatocytes and in lesser quantities by intestines, pancreas, and vascular cells. Over the years, this protease has gained importance in the field of cardiovascular biology due to its regulatory action on the low-de...
Main Authors: | Sai Sahana Sundararaman, Linsey J. F. Peters, Sumra Nazir, Andrea Bonnin Marquez, Janneke E. Bouma, Soyolmaa Bayasgalan, Yvonne Döring, Emiel P. C. van der Vorst |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/23/13026 |
Similar Items
-
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
by: Sai Sahana Sundararaman, et al.
Published: (2021-07-01) -
Inflammatory Chemokines in Atherosclerosis
by: Selin Gencer, et al.
Published: (2021-01-01) -
Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
by: Andrea Bonnin Márquez, et al.
Published: (2021-08-01) -
PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
by: Rahayu Zulkapli, et al.
Published: (2023-03-01) -
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
by: Nicolas Jacquelot, et al.
Published: (2018-10-01)